Press Releases Keyword Search Year None20232022202120202019201820172016201520142013 Jan 13, 2023 Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Jan 05, 2023 Seres Therapeutics Appoints Genomic Medicine and Microbiology Pioneer Claire M. Fraser, Ph.D., to its Board of Directors and Announces SER-155 Phase 1b Study Progress Jan 04, 2023 Seres Therapeutics to Present at 41st Annual J.P. Morgan Healthcare Conference Pagination First page « first Previous page ‹ previous Page 1 Page 2 Page 3 Current page 4
Jan 05, 2023 Seres Therapeutics Appoints Genomic Medicine and Microbiology Pioneer Claire M. Fraser, Ph.D., to its Board of Directors and Announces SER-155 Phase 1b Study Progress
